DENVER, CO / ACCESSWIRE / March 12, 2018 / Intiva BioPharma Inc. NTVA (the "Company") is aware of a civil action filed by the Securities and Exchange Commission against Jeffrey Friedland and companies associated with him. Included in the filing is a company named Intiva Pharma, LLC.
This is NOT the same company as Intiva BioPharma Inc. and Intiva BioPharma Inc. is NOT a party to this or any other lawsuit.
Intiva BioPharma Inc. also notes that Jeffrey Friedland is no longer an officer or director of the Company, as disclosed in a Form 8K report filed on March 9, 2018.
For any further information, Please contact Mark Lubchenco at 303-431-4530 or by email at mlubchenco@intivabiopharma.com.
SOURCE: Intiva BioPharma Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.